New Hope Network is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

EPAX AS Announces Successful Vitafoods Education Events

Role of Omega-3s on Age-Related Cognitive Conditions Explored

LYSAKER, Norway (May 15, 2006) - EPAX AS, a world leading supplier of highly-concentrated Omega-3 EPA/DHA fatty acid concentrates, today announced that its two education events that focused on new scientific research surrounding Omega-3s at the Vitafoods International Tradeshow and Conference held in Geneva May 9 – 11, 2006, were a complete success. The highly-credentialed Omega-3 experts, Yvonne Freund-Levi, MD, and Malcolm R. Garland MD, MRCPI, MRCPsych, DPM, discussed the findings of their studies that measured the impact of EPAX Omega-3 highly concentrated fish oils, specifically, on age-related health conditions and psychiatric disorders.

Dr. Freund-Levi, senior consultant and specialist in psychiatry and geriatrics at the Karolinska University Hospital in Sweden, presented, "Omega-3 and Alzheimer's Dementia," on May 9 in the Supplier Seminar Theatre. The public seminar focused on a new study showing the effects of Omega-3 fatty acids on Alzheimer's disease. Dr. Freund-Levi's presentation discussed the positive effects on cognition in human trials using EPAX 1050 marine Omega-3 concentrate. This study will be published later this year.

Dr. Garland, a clinical and research psychiatrist from the Royal College of Surgeons in Ireland, led a luncheon discussion on, "The Role of Omega-3 for a Healthy Mind," at the EPAX AS stand on May 10.
Dr. Garland presented research on evolutionary aspects of human diet as applied to fat intake and explored the role of n-3 EFA supplementation in supporting mental health.

"The presentations by Drs. Freund-Levi and Garland were extremely insightful," said Bjorn Refsum, CEO of EPAX AS. "The research that was discussed by these two highly respected medical professionals emphasizes the important role Omega-3s play in the human mind. We are honoured that they selected EPAX oils for use in the studies."

This year's Vitafoods show saw a 21 percent increase in attendance over last year's show and marked the ninth time EPAX AS exhibited.

EPAX AS is headquartered in Lysaker, Norway and has a GMP-approved production facility in Alesund, Norway, which is approved for API production by the Norwegian Medicines Agency. EPAX AS offers ultra pure, highly concentrated, Omega-3 EPA/DHA oils in the business-to- business segment under the brand name EPAX, available in a wide range of top quality formulas with different EPA/DHA ratios focused on specific health conditions. For further information on EPAX AS, its products or clinical studies visit or contact Gunilla Traberg at

Vitafoods International is one of the largest health ingredients industry events in Europe, attracting participants and attendees representing the nutraceutical, cosmeceutical, functional foods and drink industries. For more information visit

# # #

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.